期刊文献+

依鲁替尼对急性T淋巴细胞白血病CCRF-CEM细胞株细胞增殖的作用 被引量:2

Effect of ibrutinib on cell proliferation of acute T-lymphocyte leukemia CCRF-CEM cell lines
下载PDF
导出
摘要 目的研究依鲁替尼对急性T淋巴细胞白血病细胞CCRF-CEM细胞株增殖抑制的作用。方法使用不同浓度的依鲁替尼作用于CCRF-CEM(人急性T淋巴细胞白血病细胞)细胞株,分别作用24、48、72 h后,采用CCK8检测细胞抑制率,采用Annexin V-FITC/PI荧光双染色测定细胞的凋亡率,观察依鲁替尼对CCRF-CEM的凋亡影响。结果不同浓度依鲁替尼作用CCRF-CEM细胞后,细胞增殖抑制率明显升高(P<0.01)并且抑制率随药物浓度增高而增高。在同一浓度依鲁替尼作用细胞后,不同的作用时间,抑制率也有明显的变化(P<0.01),呈时间依懒性,但在低浓度下,72h细胞的增殖抑制率比48h低。依鲁替尼作用细胞后,细胞凋亡率明显升高(P<0.01),并且呈药物浓度依赖性。结论依鲁替尼可以诱导T淋巴细胞CCRF-CEM凋亡,并且依赖药物浓度和作用时间。 Objective To study the effect of ibrutinib on proliferation inhibition of CCRF-CEM cell lines in acute T lymphocytic leukemia cells.Methods Different concentrations of ibrutinib were used to act on CCRF-CEM(human acute T-lymphocytic leukemia) cell lines.After 24,48,and 72 h,CCK8 was used to determine the cell inhibition rate,respectively.The apoptosis rate of cells was measured by Annexin V-FITC/PI double staining and the effect of ibrutinib on the apoptosis of CCRF-CEM was observed.Results After CCRF-CEM cells were treated with different concentrations of ibrutinib,the inhibition rate of cell proliferation was significantly increased(P〈0.01),and the inhibition rate increased with the increase of drug concentration.After the cells were treated with ibrutinib at the same concentration,the inhibition rate was also changed significantly(P〈0.01).The inhibition time was time-dependent,but at low concentrations,the 72 h cell proliferation inhibition rate was lower than that of 48 h.After ibrutinib action on cells,the apoptosis rate was significantly increased(P〈0.01),and was drug-dependent.Conclusion Ibrutinib can induce apoptosis of T lymphocytes CCRF-CEM,and depends on drug concentration and duration of action.
作者 黄小勇 史海燕 李宝莉 HUANG Xiao-yong,SHI Hai-yan,LI Bao-li(Medicine College of Yan'an University, Yan'an 716000, China)
机构地区 延安大学医学院
出处 《延安大学学报(医学科学版)》 2018年第2期16-19,共4页 Journal of Yan'an University:Medical Science Edition
基金 延安大学2015年校级项目(No:YDK2015-54)
关键词 依鲁替尼 T淋巴细胞白血病 细胞凋亡 Ibrutinib T lymphocyte leukemia Apoptosis
  • 相关文献

参考文献4

二级参考文献28

  • 1Pui CH, Carroll WL, Meshinchi S, et al.Biology, risk stratifica- tion , and therapy of pediatric acute leukemias: an update[J].J Clin Oncol,2011,29(5) :551-565. 被引量:1
  • 2Pui CH, Jeha S.New therapeutic strategies for the treatment of acute lymphoblastic leukaemia [J ].Nat Rev Drug Discov, 2007,6 (2) : 149-165. 被引量:1
  • 3Schultz KR, Bowman WP, Aledo A, et al.Improved early event-free survival with imatinib in Philadelphia chromo- some-positive acute lymphoblastic leukemia: a children' s on- cology group study[J].J Clin 0ncol,2009,27(31 ):5175-5181. 被引量:1
  • 4Coustan-Smith E, Mullighan CG, Oneiu M, et al.Early T-cell precursor leukaemia: a subtype of very high-risk acute lympho- blastic leukaemia [ J ].Lancet Oncol, 2009,10 (2) : 147-156. 被引量:1
  • 5Schrappe M, Zimmermann M, Mioricke A, et al.Dexamethasone in induction can eliminate one third of all relapses in childhood acute lymphoblastic leukemia(ALL) :results of an international randomized trial in 3655 patients (Trial AEIOP-BFM ALL 2000) [C]. Am Soc Hematol Ann Meeting,2008:112,a7. 被引量:1
  • 6Mullighan CG, Miller CB, Radtke I, et al.BCR-ABLI lympho- blastic leukaemia is characterized by the deletiort of lkaros [J]. Nature, 2008,453 (7191) : 110-114. 被引量:1
  • 7Den Boer ML, van Slegtenhorst M, De Menezcs RX, et al.A sub- type of childhood acute lymphoblastic leukaemia with poor treat- ment outcome: a genome-wide classification study [J].Lancet Oncol, 2009,10 (2) : 125 - 134. 被引量:1
  • 8Mullighan CG, Su XP, Zhang JH, et al.Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia [J].N Engl J Med, 2009,360 (5) : 470-480. 被引量:1
  • 9Cario G, Zimmermann M, Romey R, et al.Presence of the P2RY8-CRLF2 rearrangement is associated with a poor progno- sis in non-high-risk precursor B-cell acute lymphoblastic leu- kemia in children treated according to the ALL-BFM 2000 pro- tocol[J].Blood, 2010,115(26) :5393-5397. 被引量:1
  • 10Mullighan CG, Collins-Underwood JR, Phillips LA, et al.Rear- rangement of CRLF2 in B-progenitor- and Down syndrome-as- sociated acute lymphoblastic leukemia [ J ].Nat Genet, 2009,41 ( 11 ) : 1243-1246. 被引量:1

共引文献35

同被引文献7

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部